Public Health Institute, Liverpool John Moores University, Exchange Station, Liverpool, L2 2QP, UK.
Public Health Institute, Liverpool John Moores University, Exchange Station, Liverpool, L2 2QP, UK.
Int J Drug Policy. 2019 Dec;74:292-298. doi: 10.1016/j.drugpo.2019.07.034. Epub 2019 Jul 26.
Studies indicate that women who have sex with women (WSW) report greater levels of drug use than heterosexual women, but globally few studies have looked at sexualised drug use among WSW. This study investigated the factors associated with drug use and sexualised drug use (SDU) among WSW.
Potential participants across the UK were invited to take part in a cross-sectional anonymous online survey between April-June 2018. The LGBT Sex and Lifestyles Survey recruited participants through Facebook advertising and social media posts from community organisations. Multivariate logistic regression was used to compare WSW who had engaged in any drug use in the past 12 months with those who had not, and those who engaged in sexualised drug use in the past 12 months with those who engaged in other drug use.
1501 WSW could be included in the analyses (mean age = 28.9, 97% white ethnicity). Any drug use was reported by 39% of WSW (n = 583), 44% of which (17% of total, n = 258) reported SDU. Factors associated with drug use were identifying as queer (aOR = 1.86, 95%CI 1.08, 3.23), younger age (aOR = 0.96, 95%CI 0.95, 0.98), being born outside the UK (aOR = 1.75, 95%CI 1.15, 2.66), recent sexual assault (aOR = 2.35, 95%CI 1.43, 3.86), > = 5 female sexual partners (aOR = 3.81, 95%CI 1.81, 8.01), and psychological distress (aOR = 1.75, 95%CI 1.15, 2.67). SDU was associated with identifying as bisexual (aOR = 2.55, 95%CI 1.69, 3.86), > = 5 female sexual partners (aOR = 4.50, 95%CI 1.91, 10.59), and highest education achieved at 16 or lower (aOR = 2.46, 95%CI 1.24, 4.90).
Some WSW may have negative experiences in relation to drug use and SDU. Harm reduction and health services that provide services for WSW should be aware of potentially compounding factors related to drug use, such as sexual assault and psychological distress, providing a safe and LGBT-friendly environment to discuss these issues.
研究表明，女同性恋者（WSW）的药物使用水平高于异性恋女性，但全球很少有研究关注 WSW 的性化药物使用。本研究调查了与 WSW 药物使用和性化药物使用（SDU）相关的因素。
英国各地的潜在参与者被邀请参加 2018 年 4 月至 6 月期间进行的横断面匿名在线调查。LGBT 性与生活方式调查通过 Facebook 广告和社区组织的社交媒体帖子招募参与者。多变量逻辑回归用于比较过去 12 个月内有任何药物使用的 WSW 与没有药物使用的 WSW，以及过去 12 个月内有性化药物使用的 WSW 与有其他药物使用的 WSW。
1501 名 WSW 可纳入分析（平均年龄 28.9，97%为白种人）。39%的 WSW 报告有任何药物使用（n=583），其中 44%（占总数的 17%，n=258）报告有 SDU。与药物使用相关的因素包括自我认同为酷儿（aOR=1.86，95%CI 1.08，3.23）、年龄较小（aOR=0.96，95%CI 0.95，0.98）、在英国境外出生（aOR=1.75，95%CI 1.15，2.66）、最近遭受性侵犯（aOR=2.35，95%CI 1.43，3.86）、有≥5 名女性性伴侣（aOR=3.81，95%CI 1.81，8.01）和心理困扰（aOR=1.75，95%CI 1.15，2.67）。SDU 与自我认同为双性恋（aOR=2.55，95%CI 1.69，3.86）、有≥5 名女性性伴侣（aOR=4.50，95%CI 1.91，10.59）和最高教育程度为 16 岁或以下（aOR=2.46，95%CI 1.24，4.90）相关。
一些 WSW 可能在药物使用和 SDU 方面有负面经历。减少伤害和为 WSW 提供服务的健康服务机构应该意识到与药物使用相关的潜在复杂因素，如性侵犯和心理困扰，提供一个安全和对 LGBT 友好的环境来讨论这些问题。
